1,10-phenanthroline has been researched along with Seizures in 1 studies
1,10-phenanthroline: RN given refers to parent cpd; inhibits Zn-dependent metalloproteinases
Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sylla-Iyarreta VeitÃa, M | 1 |
Dumas, F | 1 |
Morgant, G | 1 |
Sorenson, JR | 1 |
Frapart, Y | 1 |
Tomas, A | 1 |
1 other study available for 1,10-phenanthroline and Seizures
Article | Year |
---|---|
Synthesis, structural analysis and anticonvulsant activity of a ternary Cu(II) mononuclear complex containing 1,10-phenanthroline and the leading antiepileptic drug valproic acid.
Topics: Animals; Anticonvulsants; Copper; Crystallography, X-Ray; Electron Spin Resonance Spectroscopy; Male | 2009 |